Condition: Cancer · Sponsor: Peking Union Medical College Hospital
This is a prospective, single-center study aimed at evaluating the uptake characteristics of 68Ga-NYM096 PET/CT in various kinds of tumors including primary and metastatic lesions. Based on image analysis, this study will assess the uptake of various kinds of tumors using 68Ga-NYM096 PET/CT. The findings will provide critical insights into the tumor uptake on 68Ga-NYM096 PET/CT to identify the most promising indications for future application.
This description comes directly from the study's public registry record.
Li Huo, MD · +86 18612672038 · huoli@pumch.cn
Wenjia Zhu, MD · +86 18614080164 · zhuwenjia_pumc@163.com
Always discuss trial participation with your own doctor first.
| Peking Union Medical College Hospital, Beijing, Beijing 100730 | Beijing, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07144748